Patient adherence issues in the treatment of hepatitis C

References

• MannsMPMcHutchisonJGGordonSCPeginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialLancet200135895896511583749
   PubMed Web of Science ®Google Scholar
• FriedMWShiffmanMLReddyKRPeginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infectionN Engl J Med200234797598212324553
   PubMed Web of Science ®Google Scholar
• GhanyMGStraderDBThomasDLSeefLBAmerican Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an updateHepatology2009491335137419330875
   PubMed Web of Science ®Google Scholar
• PoordadFMcConeJJrBaconBRSPRINT-2 InvestigatorsBoceprevir for untreated chronic HCV genotype 1 infectionN Engl J Med20113641195120621449783
   PubMed Web of Science ®Google Scholar
• JacobsonIMMcHutchisonJGDusheikoGADVANCE Study TeamTelaprevir for previously untreated chronic hepatitis C virus infectionN Engl J Med20113642405241621696307
   PubMed Web of Science ®Google Scholar
• BaconBRGordonSCLawitzEHCV RESPOND-2 InvestigatorsBoceprevir for previously treated chronic HCV genotype 1 infectionN Engl J Med20113641207121721449784
   PubMed Web of Science ®Google Scholar
• ZeuzemSAndreonePPolSREALIZE Study TeamTelaprevir for retreatment of HCV infectionN Engl J Med20113642417242821696308
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL Clinical Practice Guidelines: management of hepatitis C virus infectionJ Hepatol20115524526421371579
   PubMed Web of Science ®Google Scholar
• RussoMWFriedMWSide effects of therapy for chronic hepatitis CGastroenterology20031241711171912761728
   PubMed Web of Science ®Google Scholar
• McHutchisonJGMannsMPatelKInternational Hepatitis Interventional Therapy GroupAdherence to combination therapy enhances sustained response in Genotype-1 infected patients with chronic hepatitis CGastroenterology20021231061106912360468
   PubMed Web of Science ®Google Scholar
• LarreyDChronic hepatitis C: apart from antiviral treatment what other measures should be recommended?Gastroenterol Clin Biol200226Spec No 2B283B290 French12180302
   PubMedGoogle Scholar
• WeissJJBräuNStivalaASwanTFishbeinDReview article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence researchAliment Pharmacol Ther200930142719416131
   PubMed Web of Science ®Google Scholar
• EvonDMEssermanDABonnerJERaoTFriedMWGolinCEAdherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistenceJ Viral Hepat20132053654923808992
   PubMed Web of Science ®Google Scholar
• WeissJJAlcornMCRabkinJGDieterichDTThe critical role of medication adherence in the success of boceprevir and telaprevir in clinical practiceJ Hepatol20125650350421718669
   PubMed Web of Science ®Google Scholar
• LarreyDSalseARibardDHepatitis C Network of Languedoc Roussillon (France). Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-α2a and ribavirinClin Gastroenterol Hepatol2011978178521683161
   PubMed Web of Science ®Google Scholar
• ZaniniBBeniniFPigozziMGAddicts with chronic hepatitis C: difficult to reach, manage or treat?World J Gastroenterol2013198011801924307794
   PubMed Web of Science ®Google Scholar
• ZeremskiMZibbellJEMartinezADKritzSSmithBDTalalAHHepatitis C virus control among persons who infect drugs requires overcoming barriers to careWorld J Gastroenterol2013197846785124307778
   PubMed Web of Science ®Google Scholar
• RussellMPaulyMPMooreCDThe impact of lifetime drug use on hepatitis C treatment outcomes in insured members of an integrated health care planDrug Alcohol Depend201413422222724262649
   PubMed Web of Science ®Google Scholar
• RameshSSanyalAJHepatitis C and nonalcoholic fatty liver diseaseSemin Liver Dis20042439941315605308
   PubMed Web of Science ®Google Scholar
• BurgerDBackDBuggischPClinical management of drug-drug interactions in HCV therapy: challenges and solutionsJ Hepatol20135879280023137766
   PubMed Web of Science ®Google Scholar
• Roudot-ThoravalFAbergelAAllaertFGroupe d’Etude Pour Hépavir. [Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]Gastroenterol Clin Biol20012510611066 French11910986
   PubMedGoogle Scholar
• LarreyDCouzigouPDenisJChronic hepatitis C: management of side effects of treatmentGastroenterol Clin Biol2007314S204S28 French17965631
   PubMedGoogle Scholar
• HorsmansYChronic hepatitis C, depression and interferonJ Hepatol20054278878915885347
   PubMed Web of Science ®Google Scholar
• CasteraLConstantAHenryCImpact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis CAliment Pharmacol Ther2006241223123017014581
   PubMed Web of Science ®Google Scholar
• RaisonCLBorisovASBroadwellSDDepression during pegylated interferon-alpha plus ribavirin therapy: prevalence and predictionJ Clin Psychiatry200566414815669887
   PubMed Web of Science ®Google Scholar
• HézodeCFontaineHDorivalCCUPIC Study GroupTriple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20 CUPIC)–NCT01514890J Hepatol20135943444123669289
   PubMed Web of Science ®Google Scholar
• Constitution of the World Health OrganizationChronicle of the World Health Organization1GenevaWorld Health Organization1947
   Google Scholar
• StraussEDias TeixeiraMCQuality of life in hepatitis CLiver Int20062675576516911456
   PubMed Web of Science ®Google Scholar
• SpiegelBMYounossiZMHaysRDRevickiDRobbinsSKanwalFImpact of Hepatitis C on health related quality of life: a systematic review and quantitative assessmentHepatology20054179080015791608
   PubMed Web of Science ®Google Scholar
• WareJEJrBaylissMSMannocchiaMDavisGLHealth-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy GroupHepatology19993055055510421667
   PubMed Web of Science ®Google Scholar
• LeplègeAMesbahMMarquisPPreliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1)Rev Epidemiol Sante Publique199543371379 French7667543
   PubMed Web of Science ®Google Scholar
• DaviesGLBalartLASchiffERAssessing health-related quality of life in chronic hepatitis C using the Sickness Impact ProfileClin Ther1994163343438062327
   PubMed Web of Science ®Google Scholar
• SarkarSJiangZEvonDMWahedASHoofnagleJHFatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C studyJ Hepatol20125794695222760009
   PubMed Web of Science ®Google Scholar
• McHutchisonJGWareJEJrBaylissMSHepatitis Interventional Therapy GroupThe effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ Hepatol20013414014711211891
   PubMed Web of Science ®Google Scholar
• TorranceGWFeenyDHFurlongWJBarrRDZhangYWangQMulti-attribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2Med Care1996347027228676608
   PubMed Web of Science ®Google Scholar
• YounossiZMGuyattGKiwiMBoparaiNKingDDevelopment of disease specific questionnaire to measure heath related quality of life in patients with chronic liver diseaseGut19994529530010403745
   PubMed Web of Science ®Google Scholar
• GralnekIMHaysRDKilbourneADevelopment and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease – the LDQOL 1.0Am J Gastroenterol2000953552356511151892
   PubMed Web of Science ®Google Scholar
• BaylissMSGandekBBungayKMSuganoDHsuMAWareJEJrA questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis CQual Life Res1998739559481150
   PubMed Web of Science ®Google Scholar
• RemyAJDaurèsJPTanguyGMeasurement of the quality of life in chronic hepatitis C: validation of a general index and specific index. First French resultsGastroenterol Clin Biol19992312961309 French10642618
   PubMedGoogle Scholar
• RodgerAJJolleyDThompsonSCLaniganACroftsNThe impact of diagnosis of hepatitis C virus on quality of lifeHepatology1999301299130110534353
   PubMed Web of Science ®Google Scholar
• FosterGRHepatitis C virus infection: quality of life and side effects of treatmentJ Hepatol199931 Suppl 125025410622597
   PubMed Web of Science ®Google Scholar
• BonkovskyHLWoolleyJMReduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study GroupHepatology1999292642709862876
   PubMed Web of Science ®Google Scholar
• CacoubPPoynardTGhillaniPExtrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus CArthritis Rheum1999422204221210524695
   PubMed Web of Science ®Google Scholar
• FortonDMThomasHCMurphyCAHepatitis C cognitive impairment in a cohort of patients with mild liver diseaseHepatology20023543343911826420
   PubMed Web of Science ®Google Scholar
• LaskusTRadkowskiMBednarskaADetection and analysis of hepatitis C virus sequences in cerebrospinal fluidJ Virol200276100641006812208987
   PubMed Web of Science ®Google Scholar
• HäuserWZimmerCSchiedermaierPGrandtDBiopsychosocial predictors of health-related quality of life in patients with chronic hepatitis CPsychosom Med20046695495815564364
   PubMed Web of Science ®Google Scholar
• CórdobaJFlaviàMJacasCQuality of life and cognitive function in hepatitis C at different stages of liver diseaseJ Hepatol20033923123812873820
   PubMed Web of Science ®Google Scholar
• ObhraiJHallYAnandBSAssessment of fatigue and psychologic disturbances in patients with hepatitis C virus infectionJ Clin Gastroenterol20013241341711319313
   PubMed Web of Science ®Google Scholar
• PicheTTranAFatigue in patients with chronic hepatitis C: a sign to look forGastroenterol Clin Biol20012510591060 French11910985
   PubMedGoogle Scholar
• HassaneinTCooksleyGSulkowskiMThe impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis CJ Hepatol20044067568115030985
   PubMed Web of Science ®Google Scholar
• PoynardTCacoubPRatziuVMultivirc groupFatigue in patients with chronic hepatitis CJ Viral Hepat2002929530312081607
   PubMed Web of Science ®Google Scholar
• BersteinBKleinmanJBarkerCMRevickiDAGreenJRelationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsHepatology20023570470811870387
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med200535348749716079372
   PubMed Web of Science ®Google Scholar
• WaeberBLeonettiGKollochRMcInnesGTCompliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) studyJ Hypertens1999171041104510419079
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296131011558866
   PubMed Web of Science ®Google Scholar
• CramerJRosenheckRKirkGKrolWKrystalJVA Naltrexone Study Group 425Medication compliance feedback and monitoring in a clinical trial: predictors and outcomesValue Health2003656657314627063
   PubMed Web of Science ®Google Scholar
• Dunbar-JacobJMortimer-StephensMKTreatment adherence in chronic diseaseJ Clin Epidemiol200154 Suppl 1S57S6011750211
   PubMed Web of Science ®Google Scholar
• HaynesRBMcKibbonKAKananiRSystematic review of randomised trials of interventions to assist patients to follow prescriptions for medicationsLancet19963483833868709739
   PubMed Web of Science ®Google Scholar
• MillerNHCompliance with treatment regimens in chronic asymptomatic diseasesAm J Med199710243499217586
   PubMedGoogle Scholar
• BalfourLCooperCTascaGAKaneMKowalJGarberGEvaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinicCan J Public Health20049527227715362469
   PubMed Web of Science ®Google Scholar
• ZickmundSHillisSLBarnettMJIppolitoLLaBrecqueDRHepatitis C virus-infected patients report communication problems with physiciansHepatology200439999100715057904
   PubMed Web of Science ®Google Scholar
• Organisation Mondiale de la SantéEducation Thérapeutique du Patient[Therapeutic Patient Education]GenevaWorld Health Organization1998 Available from: http://www.euro.who.int/__data/assets/pdf_file/0009/145296/E93849.pdfAccessed March 1, 2014 French
   Google Scholar
• MassipPCuzinLDelpierreCGarbayMFRousselle-KochoRchestra: une expérience pour améliorer la prise en charge globale des patients infectés par le VIH [oRchestra: an experience in order to improve the global care of HIV infected patients]Med Mal Infect200333117121 French
   Web of Science ®Google Scholar
• PradierCBentzLSpireBEfficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled studyHIV Clin Trials2003412113112671780
   PubMed Web of Science ®Google Scholar
• TuldràAWuAWInterventions to improve adherence to antiretroviral therapyJ Acquir Immune Defic Syndr200231 Suppl 3S154S15712562041
   PubMed Web of Science ®Google Scholar
• HaynesRBMcDonaldHGargAXMontaguePIntervention for helping patients to follow prescriptions for medicationsCochrane Database Syst Rev20022CD00001112076376
   PubMedGoogle Scholar
• DonnanPTMacDonaldTMMorrisADAdherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort studyDiabet Med20021927928411942998
   PubMed Web of Science ®Google Scholar
• CacoubPOuzanDMelinPPatient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational studyWorld J Gastroenterol2008146195620318985810
   PubMed Web of Science ®Google Scholar
• RenouCLahmekPParienteAImpact of therapeutic education on the outcome of chronic hepatitis C treatmentHepatology2009729A (abstract)
   Google Scholar
• Bernard-LeclercJConortOBacqYAntierDImpact d’un programme d’éducation thérapeutique sur les connaissances, l’observance et la satisfaction des patients traités pour hépatite chronique virale C [Impact of a therapeutic education program on the knowledge, the adherence and the satisfaction of the patients treated for viral chronic hepatitis C]Ther Patient Educ201132133
   Google Scholar
• LarreyDSalséACastelliCGroupe PEGOBS. Education thérapeutique systématique par une infirmière chez les patients atteints d’hépatite chronique C, traités par Interféron-Pégylé alpha2a – ribavirine (Protocole PEGOBS): impact sur la qualité de vie [Systematic therapeutic education by a nurse in patients with chronic hepatitis C, treated with pegylated interferon-alpha2a – ribavirin (PEGOBS Protocol): impact on quality of life]Gastroenterol Clin Biol20093363 (abstract CA-12). French
   Google Scholar
• LarreyDUn exemple d’éducation thérapeutique par un infirmière sur l’observance et l’efficacité du traitement par bithérapie peginterferon-alpha2-ribavirine dans l’hépatite chronique C: protocole PEGOBS [An example of therapeutic education by a nurse on compliance and efficacy of treatment with bitherapy peginterferon-alpha2-ribavirin in chronic hepatitis C: PEGOBS protocol]Bull Epidemiol Hebd20122930350354 French
   Google Scholar
• SurjadiMTorruellasCAyalaCYeeHFJrKhaliliMFormal patient education improves patient knowledge of hepatitis C in vulnerable populationsDig Dis Sci20115621321920972850
   PubMed Web of Science ®Google Scholar
• SimonDTraynardPYBourdillonFGagnayreRGrimaldiAEducation Thérapeutique Prévention et Maladies Chroniques [Therapeutic Education Prevention and Chronic Diseases]2nd edIssy les MoulineauxElsevier Masson2009 French
   Google Scholar
• ThompsonMAMugaveroMJAmicoKRGuidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panelAn Intern Med2012156817833
   PubMed Web of Science ®Google Scholar
• BourlièreMKhalounAWartelle-BladouCChronic hepatitis C: treatments of the futureClin Res Hepatol Gastroenterol201135 Suppl 2S84S9522248700
   PubMedGoogle Scholar
• OsinusiAMeissnerEGLeeYJSofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trialJAMA201331080481123982366
   PubMed Web of Science ®Google Scholar
• LawitzEMangiaAWylesDSofosbuvir for previously untreated chronic hepatitis C infectionN Engl J Med20133681878188723607594
   PubMed Web of Science ®Google Scholar
• JacobsonIMGordonSCKowdleyKVPOSITRON Study; FUSION StudySofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment optionsN Engl J Med20133681867187723607593
   PubMed Web of Science ®Google Scholar
• Chambon-AugoyardCFaureSPageauxGPDaurèsJPLarreyDGIs there a risk to develop obesity and metabolic syndrome in patients with chronic hepatitis C after treatment-induced long term virological eradication?Hepatology20115416191127A21721028
   PubMed Web of Science ®Google Scholar